Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,518 public trials 2,834 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma

NCT04696809

Conditions
Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations
  • Kameda Medical Center Chiba, Japan
  • Ogaki Municipal Hospital Gifu, Japan
  • National Hospital Organization Mito Medical Center Higashiibaraki-gun, Japan
  • Kobe City Medical Center General Hospital Kobe, Japan
View all 15 locations
View Trial Details
Completed

Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance

NCT01702831

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada
  • Vancouver General Hospital, Centennial Pavilion, 6th Floor Vancouver, British Columbia, Canada
  • Saint John Regional Hospital, 5DN Research Department, 400 University Ave Saint John, New Brunswick, Canada
  • Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada
View Trial Details
Completed

Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)

NCT04502030

Conditions
Agammaglobulinemia, Blood Protein Disorders, Chronic Disease, +18 more
Locations
  • Octapharma Research Site St. Petersburg, Florida, United States
  • Octapharma Research Site Columbus, Georgia, United States
  • Octapharma Research Site Macon, Georgia, United States
  • Octapharma Research Site New Orleans, Louisiana, United States
View all 84 locations
View Trial Details
Completed

Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP

NCT05369208

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Sobi Site 105 Toyohashi, Aichi-ken, Japan
  • Sobi Site 110 Tōon, Ehime, Japan
  • Sobi Site 118 Iizuka-shi, Fukuoka, Japan
  • Sobi Site 116 Kitakyushu, Fukuoka, Japan
View all 19 locations
View Trial Details

Related conditions